Siemens Healthineers AG
Company Profile
Business description
Siemens Healthineers is engaged in therapeutic imaging, radiotherapy, laboratory, and point-of-care diagnostics. The imaging segment (56% of sales in fiscal 2025) includes magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound. The Varian segment (18% of sales) offers radiotherapy and other oncology solutions. The diagnostics segment (19%) includes in vitro diagnostics and point-of-care diagnostics. The advanced therapies (now part of precision therapy) segment (9%) products are designed to support image-guided minimally invasive treatments in cardiology, interventional radiology, and surgery. The Americas represents 44% of total sales, Europe, Middle East, and Africa 32%, and Asia-Pacific, including China (11%), the remainder.
Contact
Siemensstrasse 3
ForchheimBY91301
DEUT: +49 9131843385
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 September 2026
Employees
74,000
Stocks News & Analysis
stocks
What did Morningstar subscribers buy and sell during August?
stocks
Tesla: Shares fall as market disappointed with Cybercab launch event
stocks
The best global tech stocks to buy
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,967.50 | 64.00 | -0.71% |
| CAC 40 | 8,156.67 | 161.31 | -1.94% |
| DAX 40 | 25,576.45 | 431.18 | -1.66% |
| Dow JONES (US) | 52,380.66 | 405.41 | -0.77% |
| FTSE 100 | 10,670.06 | 141.60 | -1.31% |
| HKSE | 24,939.15 | 335.81 | -1.33% |
| NASDAQ | 26,253.34 | 168.07 | -0.64% |
| Nikkei 225 | 64,700.43 | 442.35 | -0.68% |
| NZX 50 Index | 13,716.76 | 102.67 | -0.74% |
| S&P 500 | 7,636.36 | 37.16 | -0.48% |
| S&P/ASX 200 | 8,775.90 | 62.10 | -0.70% |
| SSE Composite Index | 3,937.78 | 13.73 | -0.35% |